Toxicity of the Immune Suppressant Cyclosporin A in the Rat

    October 1982 in “ The Journal of Pathology
    Jane T. Blair, A. W. Thomson, P.H. Whiting, R. J. L. Davidson, Simpson Jg, Jane T. Blair, A. W. Thomson, P.H. Whiting, R. J. L. Davidson, Simpson Jg
    TLDR Cyclosporin A is highly toxic to rats, causing severe health issues and death.
    The study investigated the toxicity of Cyclosporin A (Cy A) in adult Sprague-Dawley rats, administered at 100 mg/kg/24 hr for 21 days. The treatment led to significant functional and structural changes, including continuous hair loss, behavioral effects such as fits, and the death of 2 out of 8 rats. There were notable decreases in serum protein, albumin, and aspartate aminotransferase, with increases in alkaline phosphatase and bilirubin. Liver examination showed moderate fatty changes, while kidney analysis revealed proximal tubular cell vacuolation and necrosis. Cy A also caused marked lymphopenia, increased neutrophils and monocytes, reduced bone marrow cellularity, and depletion of lymphocytes in the thymus and spleen.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 24 results

    Similar Research

    5 / 1000+ results
      Obstetric Dermatology

      research Obstetric Dermatology

      January 2009 in “Springer eBooks”
      The document concludes that managing skin conditions during pregnancy is important and requires specialized care.
      Toxic Epidermal Necrolysis

      research Toxic Epidermal Necrolysis

      48 citations , November 1992 in “International Journal of Dermatology”
      Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.
      Transplantation Immunology: Solid Organ and Bone Marrow

      research Transplantation Immunology: Solid Organ and Bone Marrow

      139 citations , February 2010 in “ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology”
      Transplant success has improved with better immunosuppressive drugs and donor matching.